title: Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.
abstract: In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and the American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.
authors.affiliation: Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. l-landsberg@northwestern.edu
authors.forename: Lewis
authors.initials: L
authors.lastname: Landsberg
authors.forename: Louis J
authors.initials: LJ
authors.lastname: Aronne
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Beilin
authors.forename: Valerie
authors.initials: V
authors.lastname: Burke
authors.forename: Leon I
authors.initials: LI
authors.lastname: Igel
authors.forename: Donald
authors.initials: D
authors.lastname: Lloyd-Jones
authors.forename: James
authors.initials: J
authors.lastname: Sowers
mesh_terms: D000959:Antihypertensive Agents / Q000494:pharmacology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D008019:Life Style; D009765:Obesity / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D012306:Risk; D014481:United States / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents